Hongwei Du

9PUBLICATIONS
29CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 23, 2025
TSH Ligand-Based CAR-T Cell Effectively Eradicates TSHR-Positive Thyroid Cancer with Favorable Safety Profile.

Fei Wang, Hui Zuo, Li Liu

|Aug 25, 2025
Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results.

Niu Liu, Jiaying Wu, Enze Deng

|Apr 21, 2022
Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration.

Hongxia Li, Emily B Harrison, Huizhong Li

|Mar 10, 2022
Scattered seeding of CAR T cells in solid tumors augments anticancer efficacy.

Hongjun Li, Zejun Wang, Edikan A Ogunnaike

|Jan 14, 2022
Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors.

Jiemiao Hu, Qing Yang, Wendong Zhang

|Nov 08, 2021
Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors.

Koichi Hirabayashi, Hongwei Du, Yang Xu

Pageof 2

Frequent Collaborators

3 joint publications

Peishun Shou

3 joint publications

Gianpietro Dotti

2 joint publications

Soldano Ferrone

1 joint publications

Feifei Song